TY - JOUR
T1 - Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1
AU - Kohlhaas, Vivien
AU - Blakemore, Stuart James
AU - Al-Maarri, Mona
AU - Nickel, Nadine
AU - Pal, Martin
AU - Roth, Andreas
AU - Hövelmeyer, Nadine
AU - Schäfer, Stephan C
AU - Knittel, Gero
AU - Lohneis, Philipp
AU - Nikolic, Milos
AU - Wiederstein, Janica L
AU - Franitza, Marek
AU - Georgomonolis, Theodoros
AU - Reinart, Nina
AU - Herling, Marco
AU - Herling, Carmen
AU - Hartmann, Elena M
AU - Rosenwald, Andreas
AU - Klapper, Wolfram
AU - Büttner, Reinhard
AU - Moia, Riccardo
AU - Rossi, Davide
AU - Boldorini, Renzo
AU - Gaidano, Gianluca
AU - Frenzel, Lukas P
AU - Reinhardt, Hans Christian
AU - Brüning, Jens C
AU - Hallek, Michael
AU - Krüger, Marcus
AU - Peifer, Martin
AU - Pallasch, Christian P
AU - Wunderlich, F Thomas
N1 - © 2021 by The American Society of Hematology.
PY - 2021/2/4
Y1 - 2021/2/4
N2 - Richter’s
transformation (RT) is an aggressive lymphoma that occurs upon
progression from chronic lymphocytic leukemia (CLL). Transformation has
been associated with genetic aberrations in the CLL phase involving TP53, CDKN2A, MYC, and NOTCH1;
however, a significant proportion of RT cases lack CLL phase–associated
events. Here, we report that high levels of AKT phosphorylation occur
both in high-risk CLL patients harboring TP53 and NOTCH1 mutations as well as in patients with RT. Genetic overactivation of Akt in the murine Eµ-TCL1
CLL mouse model resulted in CLL transformation to RT with significantly
reduced survival and an aggressive lymphoma phenotype. In the absence
of recurrent mutations, we identified a profile of genomic aberrations
intermediate between CLL and diffuse large B-cell lymphoma. Multiomics
assessment by phosphoproteomic/proteomic and single-cell transcriptomic
profiles of this Akt-induced murine RT revealed an S100 protein-defined
subcluster of highly aggressive lymphoma cells that developed from CLL
cells, through activation of Notch via Notch ligand expressed by T
cells. Constitutively active Notch1 similarly induced RT of murine CLL.
We identify Akt activation as an initiator of CLL transformation toward
aggressive lymphoma by inducing Notch signaling between RT cells and
microenvironmental T cells.
AB - Richter’s
transformation (RT) is an aggressive lymphoma that occurs upon
progression from chronic lymphocytic leukemia (CLL). Transformation has
been associated with genetic aberrations in the CLL phase involving TP53, CDKN2A, MYC, and NOTCH1;
however, a significant proportion of RT cases lack CLL phase–associated
events. Here, we report that high levels of AKT phosphorylation occur
both in high-risk CLL patients harboring TP53 and NOTCH1 mutations as well as in patients with RT. Genetic overactivation of Akt in the murine Eµ-TCL1
CLL mouse model resulted in CLL transformation to RT with significantly
reduced survival and an aggressive lymphoma phenotype. In the absence
of recurrent mutations, we identified a profile of genomic aberrations
intermediate between CLL and diffuse large B-cell lymphoma. Multiomics
assessment by phosphoproteomic/proteomic and single-cell transcriptomic
profiles of this Akt-induced murine RT revealed an S100 protein-defined
subcluster of highly aggressive lymphoma cells that developed from CLL
cells, through activation of Notch via Notch ligand expressed by T
cells. Constitutively active Notch1 similarly induced RT of murine CLL.
We identify Akt activation as an initiator of CLL transformation toward
aggressive lymphoma by inducing Notch signaling between RT cells and
microenvironmental T cells.
KW - Animals
KW - Clonal Evolution
KW - Disease Progression
KW - Enzyme Activation
KW - Gene Expression Regulation, Neoplastic
KW - Genes, p53
KW - Leukemia, Lymphocytic, Chronic, B-Cell/genetics
KW - Lymphocytes, Tumor-Infiltrating/immunology
KW - Lymphoma, Large B-Cell, Diffuse/genetics
KW - Mice
KW - Mice, Inbred C57BL
KW - Neoplasm Proteins/physiology
KW - Phenotype
KW - Phosphoproteins/physiology
KW - Proto-Oncogene Proteins c-akt/genetics
KW - Receptor, Notch1/physiology
KW - Receptors, Antigen, B-Cell/immunology
KW - Signal Transduction/physiology
KW - Transcriptome
KW - Tumor Microenvironment
KW - Tumor Suppressor Protein p53/physiology
KW - Up-Regulation
U2 - 10.1182/blood.2020005734
DO - 10.1182/blood.2020005734
M3 - Article
C2 - 33538798
SN - 0006-4971
VL - 137
SP - 646
EP - 660
JO - Blood
JF - Blood
IS - 5
ER -